Hybrid approach for management of end-stage heart failure in complex congenital heart disease

Chiara Tessari; Biagio Castaldi; Giuseppe Toscano; Vladimiro L Vida; Gino Gerosa; Massimo A Padalino

doi:10.1177/03913988221109285

Hybrid approach for management of end-stage heart failure in complex congenital heart disease

Int J Artif Organs. 2022 Aug;45(8):722-725. doi: 10.1177/03913988221109285. Epub 2022 Jun 28.

Authors

Chiara Tessari¹, Biagio Castaldi², Giuseppe Toscano¹, Vladimiro L Vida³, Gino Gerosa¹, Massimo A Padalino³

Affiliations

¹ Cardiac Surgery Unit, Department of Cardio-Thoracic-Vascular Sciences and Public Health, University of Padova, Padova, Italy.
² Pediatric Cardiology Unit, Department of Women's and Children's Health, University of Padova, Padova, Italy.
³ Pediatric Cardiac Surgery Unit, Department of Cardio-Thoracic-Vascular Sciences and Public Health, University of Padova, Padova, Italy.

PMID: 35762855
DOI: 10.1177/03913988221109285

Abstract

Management of end-stage heart failure (ESHF) in children with congenital heart disease is challenging. We report a step-by-step hybrid procedure (transcatheter pulmonary valve and left mechanical assist device implantations) in a child with ESHF after repair of tetralogy of Fallot, as an effective bridge to transplant strategy.

Keywords: Congenital-heart-disease; left-ventricular assist device; transcatheter pulmonary valve.

MeSH terms

Child
Heart Defects, Congenital* / complications
Heart Defects, Congenital* / surgery
Heart Failure* / etiology
Heart Failure* / surgery
Humans
Pulmonary Valve* / surgery
Treatment Outcome